Moreover, Hughes et al. reported that a first-trimester combining PAPP-A, PlGF, sFlt-1, and clinical risk factors achieved high accuracy for preeclampsia screening, though cost and complex ultrasound limit its use [114]. This evidence concerns the gene PAPPA and preeclampsia.